← Back
$SGMO All transactions

SANGAMO THERAPEUTICS, INC

A

$ Value

$0

Shares

25,000

Price

$0

Filed

Jun 16

Insider

Name

Markels John

Title

CIK

0001803424

Roles

Director

Transaction Details

Transaction Date

2025-06-12

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

96,384

Footnotes

Represents shares of common stock issuable upon settlement of a restricted stock unit ("RSU") grant that will fully vest on the earlier of (a) June 12, 2026 or (b) the day prior to the 2026 annual meeting of stockholders, subject to the Reporting Person's Continuous Service (as defined in the Issuer's Amended and Restated 2018 Equity Incentive Plan, as amended (the "2018 EIP")) through such date and subject to acceleration as provided in the 2018 EIP. | The option is immediately exercisable in full, but any unvested shares that are purchased under the option are subject to certain repurchase rights by the Issuer upon cessation of the Reporting Person's Continuous Service (as defined in the 2018 EIP). The shares subject to the option will vest in 12 successive equal monthly installments following the grant date, subject to the Reporting Person's Continuous Service (as defined in the 2018 EIP) through each such date and subject to acceleration as provided in the 2018 EIP.

Filing Info

Accession No.

0001415889-25-017371

Form Type

4

Issuer CIK

0001001233

Markels John's History

Date Ticker Type Value
2025-06-12 SGMO A $0
2025-06-12 SGMO A $0
2025-06-09 ARCT A $0

Other Insiders at SGMO (90d)

Insider Bought Sold Last
Macrae Sandy
PRESIDENT, CEO AND DIRECTOR
2026-04-01
Willoughby Scott B.
SVP, CHIEF LEGAL OFFICER, SECY
2026-04-01
Dubois-Stringfellow Nathalie
SVP-CHIEF DEVELOPMENT OFFICER
$89K 2026-04-21
Davis Gregory D
Head of Research & Technology
$18K 2026-04-22
Jain Nikunj
Principal Accounting Officer
2026-04-01